Christine Durand, MD

Primary Academic Title

Associate Professor of Medicine

Background

X Profile

https://www.twitter.com/CMDurandMD

Find a Clinical Trial

Recent News Articles and Media Coverage

• New Medications May Increase Available Organs for Transplant, National Geographic (August 9, 2018)

  Study Aims to Show Transplant Between HIV-Positive Patients are Safe, Save Lives, NPR (June 1, 2018)

  Study Shows 1 in 8 Organ Transplants in the U.S. Come from Donors who Died from Overdoses, Vice (April 16, 2018)

  HCV-Positive to HCV-Negative Transparent Recipients Remain Uninfected after 1 Year, Healio (March 13, 2018)

  Doctors Tried Transplants Using Diseased Organs. One Year Later, the Recipients Are Still Disease-Free, Time (March 5, 2018)

Additional Academic Titles

Associate Professor of Oncology

Research Interests

Organ transplantation in persons living with HIV and hepatitis C

Lab Website

Christine Durand Lab

• Dr. Christine Durand, assistant professor of medicine and oncology and member of the Johns Hopkins Kimmel Cancer Center, is involved in clinical and translational research focused on individuals infected with HIV and hepatitis C virus who require cancer and transplant therapies. Her current research efforts include looking at outcomes of hepatitis C treatment after solid organ transplant, the potential use of organs from HIV-infected donors for HIV-infected solid organ transplant candidates, and HIV cure strategies including bone marrow transplantation. Dr. Durand is supported by multiple grants: - R01 from the National Institute of Allergy and Infectious Diseases (NIAID) to study HIV-to-HIV organ transplantation in the US. - K23 from the National Cancer Institute (NCI) to study antiretroviral therapy during bone marrow transplant in HIV-1 infection. - U01 from the NIAID to study HIV-to-HIV deceased donor kidney transplantation. U01 from the NIAID to study HIV-to-HIV deceased donor liver transplantation.